Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jan 25 | SUPN Supernus Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 9.13 | 20,000 | 182.60 k | 48,395 |
22 Jan 25 | SUPN Supernus Pharmaceuticals | Director Stock Option Common Stock | Option exercise | Dispose M | No | No | 9.13 | 20,000 | 182.60 k | 0 |
8 Nov 24 | SUPN Supernus Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 36.28 | 8,722 | 316.43 k | 28,395 |
11 Jun 24 | SCPH scPharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 4.11 | 19,750 | 81.17 k | 19,750 |
23 Feb 24 | SUPN Supernus Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 3,886 | 0.00 | 37,117 |
23 Feb 24 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 3,886 | 0.00 | 0 |
22 Feb 24 | SUPN Supernus Pharmaceuticals | RSU Common Stock | Grant | Acquire A | No | No | 0 | 5,369 | 0.00 | 5,369 |
22 Feb 24 | SUPN Supernus Pharmaceuticals | Director Stock Option Common Stock | Grant | Acquire A | No | No | 27.94 | 8,252 | 230.56 k | 8,252 |